VIROVEK'S

BAC-TO-AAV TECHNOLOGY

FOR LARGE SCALE AAV PRODUCTION

Promotions & Discounts

Special offer for all academic and non-profit organizations on Virovek's custom-made AAV vectors.  More

Peer-Reviewed Articles Citing Virovek’s Published Work

Selected Peer-Reviewed Articles Citing Virovek's Published Work
Gray JT, Zolotukhin S. Design and construction of functional AAV vectors. Methods Mol Biol. 2011;807:25-46. PMID: 22034025 PMID: 22034025; PDF
Galibert L, Merten OW. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases. J Invertebr Pathol. 2011 Jul;107 Suppl:S80-93. PMID: 21784234
Lu H, Qu G, Yang X, Xu R, Xiao W. Systemic elimination of de novo capsid protein synthesis from replication-competent AAV contamination in the liver. Hum Gene Ther. 2011 May;22(5):625-32. PMID: 21244243; PDF
Smith RH, Levy JR, Kotin RM. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther. 2009 Nov;17(11):1888-96. PMID: 19532142; PDF
Aslandi G. Lamb K, Zolotukhin S. An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc Natl Acad Sci USA. 2009 Mar 31;106(13):5059-64. PMID: 19279219; PDF
Cecchini S, Negrete A, Virag T, Graham BS, Cohen JI, Kotin RM. Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States. Clin Vaccine Immunol. 2009 May;16(5):597-604. PMID: 19244471; PDF
Youjin S, Jun Y. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy. Biotechnol Lett. 2009 Mar;31(3):321-8. PMID: 18979215; PDF